News Focus
News Focus
icon url

Tuff-Stuff

08/30/11 7:30 AM

#405080 RE: Tuff-Stuff #405079

CYCC $ 0.83 announces start of novel gene-based Ph 2 trial for sapacitabine in CLL/SLL patients w/ chromosome 11q22-23 deletion #biotech